Health knowledge made personal
WellPage for Chronic Lymphocytic Leukemia Cll
+ Bookmark › Share
Go
Search posts:

Chronic Lymphocytic Leukemia Cll - Articles

Aarkstore Enterprise Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010 by Aarkstore Posted Tue 18 Jan 2011 7:29am Aarkstore announce a new report  "Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010 " through its vast collection of market research report. Summary “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, Q4, 2010 provides data on the Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This re ... Read on »
Natural Therapies for Chronic Lymphocytic Leukemia by Melissa G. Patient ExpertComplimentary & Alternative Medicine Posted Tue 11 Sep 2012 8:34am As a lymphatic drainage therapist, I work with many cancer patients in varying phases of their cancer recovery. It seems like we've been seeing more Chronic Lymphocytic Leukemia (CLL) recently and I thought it would be a good idea to provide some recommendation for natural treatments and natural therapies for these individuals to consider in ... Read on »
Penn researchers find genetically modified T cells cause sustained remissions in patients with chronic lymphocytic leukemia: by Cancer.gov Posted Sat 13 Aug 2011 10:19pm Penn researchers find genetically modified T cells cause sustained remissions in patients with chronic lymphocytic leukemia: NCI Cancer Center News Researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced ch ... Read on »
FDA Approves New Treatment for Chronic Lymphocytic Leukemia by Health: Hearsay & Headlines Posted Tue 27 Oct 2009 11:03pm The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow. Arzerra is approved for patients with CLL whose cancer is no longer being controlled by other forms of chemotherapy. CLL primarily affects people older th ... Read on »
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia by Health: Hearsay & Headlines Posted Thu 18 Feb 2010 12:00am /PRNewswire/ -- The U.S. Food and Drug Administration today approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer. Rituxan, an anti-cancer drug, is intended for patients with CLL who are beginning chemotherapy for the first time and for those who hav ... Read on »
Rituxan Approved to Treat Chronic Lymphocytic Leukemia by MedNews Patient Expert Posted Thu 18 Feb 2010 8:27pm The U.S. Food and Drug Administration (FDA) has approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer. Rituxan, an anti-cancer drug, is intended for patients with C ... Read on »
Rituxan Approved to Treat Chronic Lymphocytic Leukemia by MedNews Patient Expert Posted Mon 29 Nov 1999 4:00pm The U.S. Food and Drug Administration (FDA) has approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer. Rituxan, an anti-cancer drug, is intended for patients with CLL who are beginning chemotherapy for the first time and for those who have ... Read on »
Chronic Lymphocytic Leukemia by catattack Posted Fri 19 Jun 2009 10:13pm Chronic Lymphocytic Leukemia, otherwise known as CLL or cancer of the blood cells, is the most common type of adult leukemia. CLL accounts for nearly one-third of all leukemia cases. The average age of diagnosis is 72. The May 2009 issue of NARFE magazine has a terrific article on CLL by Dr. Marilyn S. Radke. She says: "Leukemia starts ... Read on »
B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia by nih.gov Posted Sun 11 Oct 2009 5:00pm Description of Invention: B-cell chronic lymphocytic leukemia (B-CLL) is a cancer characterized by a progressive accumulation of functionally incompetent lymphocytes. Despite high morbidity and mortality, the only available potential cure is allogeneic hematopoietic stem cell transplantation (alloHSCST). However, there is le ... Read on »
Leukemia Therapeutics Market to 2018 by MarketResearchReports Posted Tue 06 Nov 2012 11:18am Dear fellow readers we are happy to announce that we have added a new report named   Leukemia Therapeutics Market to 2018 The report provides an in-depth analysis of the major leukemia indications including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML) and chronic myelocytic leukemia (C ... Read on »